George Witter, Managing Director

George joins CiME as Managing Director. A 15 year CME veteran, George started his career with Genentech as a Clinical Marketing Specialist in 1985. Over 10 years he held posts as Regional Marketing Manager and Division Manager. After leaving Genentech in 1995, George held senior management positions in two startup companies, one of which went public and his own CME company which he owned for 11 years. George brings a great deal of experience in CME to CiME and deep relationships with major healthcare associations like the American Diabetes Association, American Heart Association, American College of Chest Physicians and academic providers like Johns Hopkins, the University of Pennsylvania and Temple University.

Dr. Chris  Blagden, Medical Director

Chris joins CiME as Medical Director. Chris did his Post Doc in Molecular Neurobiology at NYU School of Medicine and earned his PhD in Development Neurobiology from Kings College in London. He brings 10 years of medical education and communications expertiseto CiME and is well experienced in Neuroscience (acute and chronic pain, schizophrenia, bipolar disorder depression, addiction ADHD, Alzheimer’s, sleep disorders and fibromyalgia). Additionally he had created and managed  multiple CME activities in other key disease states including cardiovascular disease, infectious disease, virology, critical care therapeutics, gastroenterology, transplant medicine and fertility.